Page last updated: 2024-09-04

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and ST Elevation Myocardial Infarction

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine has been researched along with ST Elevation Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Harris, J; Johnson, TW; Lasserson, D; Loke, YK; Mahadevan, K; Mumford, A; Pouwels, K; Pufulete, M; Reeves, BC1

Trials

1 trial(s) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and ST Elevation Myocardial Infarction

ArticleYear
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'targe
    Open heart, 2022, Volume: 9, Issue:2

    Topics: Acute Coronary Syndrome; Adolescent; Aspirin; Clopidogrel; Cohort Studies; Dinucleoside Phosphates; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor

2022